Michelle Legacy, DO
Dermatology · Waterford, MINPI 1982855110
Payments from drug & device makers
Across 327 payments — averaging $21.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$935
- AbbVie$579
- Galderma Laboratories, L.p.$575
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$367
- Almirall LLC$347
- Novartis$332
- plus $4K from 32 others
What the payments were for
- Food & beverage$6,98898%
- Education$1462%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 47 | $935 |
| AbbVie(2 entities) | 25 | $579 |
| Galderma Laboratories, L.p. | 39 | $575 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 15 | $367 |
| Almirall LLC | 11 | $347 |
| Novartis | 17 | $332 |
| VYNE Pharmaceuticals Inc. | 18 | $307 |
| Regeneron Healthcare Solutions, Inc. | 11 | $297 |
| UCB, Inc. | 6 | $292 |
| Janssen Scientific Affairs, LLC | 3 | $274 |
| Sun Pharmaceutical Industries Inc. | 12 | $265 |
| Lilly USA, LLC | 9 | $259 |
| LEO Pharma Inc. | 12 | $245 |
| Mayne Pharma Commercial LLC | 17 | $236 |
| Genentech USA, Inc. | 11 | $219 |
| EPI Health, LLC | 8 | $187 |
| Sanofi | 7 | $184 |
| Pfizer | 9 | $162 |
| E.r. Squibb & Sons, L.L.C. | 8 | $147 |
| Bristol Myers Squibb | 5 | $115 |
| Amgen | 4 | $98 |
| Boehringer Ingelheim | 3 | $97 |
| Incyte Corporation | 4 | $92 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| Dermavant Sciences, Inc. | 3 | $60 |
| Encore Dermatology Inc. | 3 | $58 |
| Journey Medical Corporation | 2 | $51 |
| Aclaris Therapeutics, Inc. | 2 | $41 |
| DUSA Pharmaceuticals, Inc. | 2 | $37 |
| Revance Therapeutics, Inc. | 1 | $32 |
| Merz North America, Inc. | 1 | $29 |
| Kerecis Limited | 1 | $26 |
| Organon | 1 | $25 |
| Merck | 2 | $24 |
| Dermira, Inc. | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Mission Pharmacal Company | 1 | $16 |
| Organogenesis Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,134 in reported general payments places this provider in the 70th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 11 | $30,471 |
| Fluorouracil | 34 | $1,959 |
| Ciclopirox | 17 | $943 |
| Clindamycin Phosphate | 13 | $480 |
| Doxycycline Hyclate | 18 | $367 |
| Ketoconazole | 19 | $319 |
| Fluconazole | 20 | $271 |
| Triamcinolone Acetonide | 19 | $110 |
| Mupirocin | 19 | $106 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Waterford
- Michael SiegelWaterford$708K
- Johann GudjonssonAnn Arbor$15.9M
- Ali MoiinTroy$9.9M
- Linda Stein GoldWest Bloomfield$7.5M
- Wendy McFaldaClarkston$3.6M
- Kristi HawleyCaledonia$2.5M
- Brent BoyceSebewaing$2.2M
- David AltmanWarren$1.9M
- Christofer BuattiAuburn Hills$1.6M
- Mio NakamuraAnn Arbor$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.